[Ovid] Mild liver function decline in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma: a real-world study

noona Post time 6 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-12 04:49
Reward10points

journal:European Journal of Gastroenterology & Hepatology

Authors:Victoria Delhoume; Paul Girot; Marion Khaldi; Juliette Boilève; Mava Salimon; Yann Touchefeu

Published date:2026-2-

DOI:10.1097/meg.0000000000003075

PDF link:https://journals.lww.com/10.1097/MEG.0000000000003075

Article link:https://doi.org/10.1097/meg.0000000000003075

Article Source:Ovid Technologies (Wolters Kluwer Health)


Remark:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
jakir_ete_ruet Post time 6 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list